Timothy . Yap has been appointed as Editor-in-Chief of Clinical Cancer Research
Listed on 2026-07-20
-
Research/Development
Overview
AACR announces the appointment of Timothy
A. Yap, MBBS, PhD, as Editor-in-Chief of Clinical Cancer Research.
Dr. Timothy
A. Yap is a Medical Oncologist and Physician-Scientist at the University of Texas MD Anderson Cancer Center. He serves in leadership roles related to clinical development and translational research, including positions in other institutes and collaborations focused on personalized cancer therapy and biomarker-driven studies.
Dr. Yap has held multiple leadership and advisory roles within the AACR and has contributed to conferences, workshops, and clinical trials committees. He is involved in advancing translational research and early-phase clinical development in oncology.
Clinical and research focusHis work centers on first-in-human and combination therapy development for molecularly targeted agents and immunotherapies, incorporating predictive biomarkers to guide treatment decisions. Interests include DNA damage response inhibitors, cell cycle regulators, and exploration of novel targeted therapies and immunotherapies.
Education and trainingDr. Yap earned his medical degree and completed training in immunology and infectious diseases, with studies at Imperial College London and related institutions.
NoteThis description focuses on biographical and professional context related to the appointment. It does not constitute a job posting or outline a candidate’s responsibilities, qualifications, or benefits for a specific role.
#J-18808-Ljbffr(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).